---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-25-000009"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T06:03:36.517905+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q2 non-GAAP EPS $1.93 (+2% YoY); guides FY25 $7.85-8.00, closes GI Alliance deal

## Summary
- Revenue $55.3B (-4% YoY; +16% ex-large customer expiration); GAAP EPS $1.65, non-GAAP EPS $1.93.
- Pharm & Specialty segment profit $531M (+7%); Global Medical Products profit $18M vs $11M.
- FY2025 non-GAAP EPS guidance raised to $7.85-$8.00 from $7.75-$7.90; segment profit growth revised.
- Completed acquisition of 73% of GI Alliance (gastroenterology MSO) and ION acquisition in Dec.
- Started commercial-scale production of actinium-225 for theranostics; new distribution center underway.

## SEC filing metadata
- accession: 0000721371-25-000009
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137125000009/0000721371-25-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000009/cah-20250130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-25-000009
- JSON: https://secwatch.observer/filing/0000721371-25-000009.json
- Plain text: https://secwatch.observer/filing/0000721371-25-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.